drugset / Trial / NCT03375957
Sensitization Study of ATx201 in Healthy Volunteers
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a Phase I, single-site study to evaluate the sensitization potential of topically applied ATx201 GEL, 2% and 4%, along with a placebo control, in healthy human subjects.
Timeline
- Start
- 2018-01-08
- Primary completion
- 2018-02-17
- Completion
- 2018-03-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ATx201 | Unknown | 2 % | Topical |
| Subject | ATx201 | Unknown | 4 % | Topical |
Indications
No indication recorded.